X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ELDER PHARMA - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES ELDER PHARMA PIRAMAL ENTERPRISES/
ELDER PHARMA
 
P/E (TTM) x 9.5 -0.2 - View Chart
P/BV x 1.6 0.1 1,627.8% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 PIRAMAL ENTERPRISES   ELDER PHARMA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-18
ELDER PHARMA
Jun-14
PIRAMAL ENTERPRISES/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs3,083380 811.3%   
Low Rs1,902188 1,011.7%   
Sales per share (Unadj.) Rs589.7491.2 120.1%  
Earnings per share (Unadj.) Rs284.0-3.2 -8,927.4%  
Cash flow per share (Unadj.) Rs310.514.4 2,155.1%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs1,467.0376.5 389.6%  
Shares outstanding (eoy) m180.2720.54 877.7%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x4.20.6 731.0%   
Avg P/E ratio x8.8-89.3 -9.8%  
P/CF ratio (eoy) x8.019.7 40.7%  
Price / Book Value ratio x1.70.8 225.3%  
Dividend payout %8.80-   
Avg Mkt Cap Rs m449,3325,833 7,702.8%   
No. of employees `0006.8NA-   
Total wages/salary Rs m19,8812,179 912.4%   
Avg. sales/employee Rs Th15,535.6NM-  
Avg. wages/employee Rs Th2,905.4NM-  
Avg. net profit/employee Rs Th7,482.5NM-  
INCOME DATA
Net Sales Rs m106,31010,089 1,053.7%  
Other income Rs m2,595257 1,011.4%   
Total revenues Rs m108,90610,346 1,052.7%   
Gross profit Rs m51,599-792 -6,515.8%  
Depreciation Rs m4,773361 1,321.1%   
Interest Rs m29,7832,756 1,080.5%   
Profit before tax Rs m19,638-3,653 -537.6%   
Minority Interest Rs m2,8010-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m-28,764125 -22,983.8%   
Profit after tax Rs m51,203-65 -78,351.6%  
Gross profit margin %48.5-7.8 -618.4%  
Effective tax rate %-146.5-3.4 4,275.3%   
Net profit margin %48.2-0.6 -7,435.7%  
BALANCE SHEET DATA
Current assets Rs m118,1549,240 1,278.7%   
Current liabilities Rs m462,2609,998 4,623.7%   
Net working cap to sales %-323.7-7.5 4,310.0%  
Current ratio x0.30.9 27.7%  
Inventory Days Days2746 57.4%  
Debtors Days Days4760 77.6%  
Net fixed assets Rs m113,72710,124 1,123.4%   
Share capital Rs m361206 175.3%   
"Free" reserves Rs m264,0935,582 4,730.9%   
Net worth Rs m264,4547,734 3,419.6%   
Long term debt Rs m242,2064,889 4,954.1%   
Total assets Rs m726,83422,882 3,176.4%  
Interest coverage x1.7-0.3 -510.1%   
Debt to equity ratio x0.90.6 144.9%  
Sales to assets ratio x0.10.4 33.2%   
Return on assets %11.111.8 94.7%  
Return on equity %19.4-0.8 -2,291.3%  
Return on capital %10.322.3 46.2%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m15,110307 4,928.2%   
Fx outflow Rs m4,298125 3,429.8%   
Net fx Rs m10,813181 5,963.9%   
CASH FLOW
From Operations Rs m-159,66611,754 -1,358.4%  
From Investments Rs m-17,677-561 3,153.8%  
From Financial Activity Rs m186,503-6,762 -2,758.2%  
Net Cashflow Rs m9,3644,432 211.3%  

Share Holding

Indian Promoters % 52.9 39.6 133.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 7.5 53.3%  
FIIs % 26.6 16.8 158.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 36.1 45.7%  
Shareholders   93,274 16,479 566.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Sell-Off; Sensex Slumps Over 530 Points(Closing)

Share markets in India continued their sell-off seen during the last week and ended the day deep in the red. All sectoral indices traded on a negative note.

Related Views on News

BIRLA CORP Plunges by 6%; BSE 500 Index Down 1.4% (Market Updates)

Sep 24, 2018 | Updated on Sep 24, 2018

BIRLA CORP share price has plunged by 6% and its current market price is Rs 690. The BSE 500 is down by 1.4%. The top gainers in the BSE 500 Index are GMR INFRA (up 4.9%) and TCS (up 3.3%). The top losers are BIRLA CORP (down 5.7%) and PIRAMAL ENTERPRISES (down 5.3%).

The BSE HEALTHCARE Index Down 2% ; CAPLIN POINT Among Top Losers (Market Updates)

Sep 24, 2018 | Updated on Sep 24, 2018

The BSE HEALTHCARE Index Down at 15,697 (down 2.1%). Among the top losers in the BSE HEALTHCARE Index today are CAPLIN POINT, VIMTA LABS and PIRAMAL ENTERPRISES. Meanwhile, the BSE Sensex has plunged 1.2% to 36,946.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Sep 24, 2018 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS